HK1087105A1 - Benzofuran derivative - Google Patents
Benzofuran derivativeInfo
- Publication number
- HK1087105A1 HK1087105A1 HK06107242A HK06107242A HK1087105A1 HK 1087105 A1 HK1087105 A1 HK 1087105A1 HK 06107242 A HK06107242 A HK 06107242A HK 06107242 A HK06107242 A HK 06107242A HK 1087105 A1 HK1087105 A1 HK 1087105A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- benzofuran derivative
- benzofuran
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45256403P | 2003-03-07 | 2003-03-07 | |
PCT/JP2004/002633 WO2004078751A1 (ja) | 2003-03-07 | 2004-03-03 | ベンゾフラン誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1087105A1 true HK1087105A1 (en) | 2006-10-06 |
Family
ID=32962732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06107242A HK1087105A1 (en) | 2003-03-07 | 2006-06-27 | Benzofuran derivative |
Country Status (16)
Country | Link |
---|---|
US (1) | US7314877B2 (ko) |
EP (1) | EP1602655A4 (ko) |
JP (1) | JP4528722B2 (ko) |
KR (1) | KR20050105982A (ko) |
CN (1) | CN1326852C (ko) |
AU (1) | AU2004218161B9 (ko) |
BR (1) | BRPI0407519A (ko) |
CA (1) | CA2512280A1 (ko) |
HK (1) | HK1087105A1 (ko) |
MX (1) | MXPA05009500A (ko) |
MY (1) | MY137964A (ko) |
NO (1) | NO20053312L (ko) |
NZ (1) | NZ541064A (ko) |
RU (1) | RU2328495C2 (ko) |
TW (1) | TWI281397B (ko) |
WO (1) | WO2004078751A1 (ko) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1759103A (zh) | 2003-03-18 | 2006-04-12 | 兴和株式会社 | 水溶性苯基哒嗪衍生物及含有该衍生物的医药品 |
EP1604988A1 (en) * | 2004-05-18 | 2005-12-14 | Sanofi-Aventis Deutschland GmbH | Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals |
DE102005057924A1 (de) * | 2005-12-05 | 2007-06-06 | Merck Patent Gmbh | Pyridazinonderivate |
KR20080105048A (ko) * | 2006-03-09 | 2008-12-03 | 옴 파르마 | 면역조절 화합물 및 염증성 사이토킨의 과생성에 관련된 질병의 치료 |
FR2941947B1 (fr) * | 2009-02-12 | 2011-03-25 | Sanofi Aventis | Derives de 3-benzofuranyl-indol-2-one subtitues en 3, leur preparation et leur application en therapeutique |
CN101845032B (zh) * | 2010-06-03 | 2011-11-30 | 广东德鑫制药有限公司 | 一种酚类化合物及用途 |
KR101734868B1 (ko) | 2010-07-22 | 2017-05-12 | 후소 야쿠힝 고교 가부시끼가이샤 | 벤조푸라논 화합물 및 그것을 포함하는 의약 조성물 |
SG191945A1 (en) * | 2011-01-14 | 2013-08-30 | Vertex Pharma | Process of making gyrase and topoisomerase iv inhibitors |
AU2011380572B2 (en) | 2011-10-31 | 2016-05-26 | Korea Electric Power Corporation | Solid carbon dioxide absorbent including amine or a compound thereof for use in the capturing process of dry carbon dioxide, and method for manufacturing same |
KR101652199B1 (ko) * | 2015-06-03 | 2016-08-30 | 영남대학교 산학협력단 | 신규 벤조퓨란온 유도체 화합물, 이의 제조 방법 및 이를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 조성물 |
KR20180006522A (ko) | 2016-07-07 | 2018-01-18 | 삼성디스플레이 주식회사 | 액정 조성물 및 이를 포함하는 액정 표시 장치 |
CN108440468B (zh) * | 2018-04-17 | 2022-09-23 | 南华大学 | 2-(苯并呋喃-5-基)苯酚及其作为抗癌药物的应用 |
WO2020097266A1 (en) | 2018-11-06 | 2020-05-14 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3093507B2 (ja) | 1993-02-15 | 2000-10-03 | キヤノン株式会社 | 液晶性化合物、これを含む液晶組成物、それを有する液晶素子、それらを用いた表示方法および表示装置 |
AU2521597A (en) | 1996-04-12 | 1997-11-07 | Sumitomo Pharmaceuticals Company, Limited | Piperidinylpyramidine derivatives |
JP3337992B2 (ja) | 1997-11-04 | 2002-10-28 | ファイザー製薬株式会社 | 5−置換ピコリン酸化合物及びその製造方法 |
CN1142148C (zh) * | 1997-11-19 | 2004-03-17 | 兴和株式会社 | 新颖的哒嗪衍生物和含有其作为有效成分的药物 |
TWI241295B (en) * | 1998-03-02 | 2005-10-11 | Kowa Co | Pyridazine derivative and medicine containing the same as effect component |
JP2000247959A (ja) * | 1999-02-26 | 2000-09-12 | Kowa Co | ピリダジン−3−オン誘導体及びこれを含有する医薬 |
JP2000290261A (ja) * | 1999-04-01 | 2000-10-17 | Mitsui Chemicals Inc | ジヒドロピリダジノン誘導体およびそれを有効成分として含有する腫瘍壊死因子産生抑制剤 |
WO2001022966A1 (en) | 1999-09-30 | 2001-04-05 | Smithkline Beecham Corporation | Caspases and apoptosis |
JP4502435B2 (ja) | 1999-11-30 | 2010-07-14 | 興和創薬株式会社 | 4,5,6,7−テトラヒドロチエノ〔2,3−c〕ピリジン系化合物 |
JP4548882B2 (ja) | 1999-11-30 | 2010-09-22 | 興和創薬株式会社 | 4,5,6,7−テトラヒドロチエノ〔2,3−c〕ピリジン化合物 |
JP4548884B2 (ja) | 1999-12-03 | 2010-09-22 | 興和創薬株式会社 | 4,5,6,7−テトラヒドロチエノ〔2,3−c〕ピリジン誘導体 |
AU2001230584A1 (en) | 2000-02-09 | 2001-08-20 | Hokuriku Seiyaku Co., Ltd. | 1h-imidazopyridine derivatives |
WO2001062751A1 (en) | 2000-02-21 | 2001-08-30 | Astrazeneca Ab | Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
WO2001062715A1 (en) | 2000-02-24 | 2001-08-30 | Smithkline Beecham P.L.C. | Novel cd23 inhibitors |
ES2317889T3 (es) | 2000-03-01 | 2009-05-01 | Janssen Pharmaceutica Nv | Derivados de tiazolilo 2,4-disustituido. |
US6664256B1 (en) * | 2000-07-10 | 2003-12-16 | Kowa Co., Ltd. | Phenylpyridazine compounds and medicines containing the same |
US6861428B2 (en) * | 2001-09-26 | 2005-03-01 | Kowa Co., Ltd. | Water-soluble phenylpyridazine compounds and compositions containing the same |
KR20040039377A (ko) * | 2001-09-26 | 2004-05-10 | 코와 가부시키가이샤 | 수용성 페닐피리다진 유도체 및 이를 함유하는 의약 |
JP3774710B2 (ja) | 2003-06-27 | 2006-05-17 | 横浜ゴム株式会社 | 空気入りタイヤ |
-
2004
- 2004-03-03 WO PCT/JP2004/002633 patent/WO2004078751A1/ja active Application Filing
- 2004-03-03 CN CNB2004800059391A patent/CN1326852C/zh not_active Expired - Fee Related
- 2004-03-03 JP JP2005503069A patent/JP4528722B2/ja not_active Expired - Fee Related
- 2004-03-03 MX MXPA05009500A patent/MXPA05009500A/es active IP Right Grant
- 2004-03-03 RU RU2005131018/04A patent/RU2328495C2/ru not_active IP Right Cessation
- 2004-03-03 NZ NZ541064A patent/NZ541064A/en unknown
- 2004-03-03 US US10/547,779 patent/US7314877B2/en not_active Expired - Fee Related
- 2004-03-03 CA CA002512280A patent/CA2512280A1/en not_active Abandoned
- 2004-03-03 AU AU2004218161A patent/AU2004218161B9/en not_active Ceased
- 2004-03-03 KR KR1020057012914A patent/KR20050105982A/ko not_active Application Discontinuation
- 2004-03-03 BR BRPI0407519-6A patent/BRPI0407519A/pt not_active IP Right Cessation
- 2004-03-03 EP EP04716775A patent/EP1602655A4/en not_active Withdrawn
- 2004-03-05 MY MYPI20040776A patent/MY137964A/en unknown
- 2004-03-05 TW TW093105878A patent/TWI281397B/zh not_active IP Right Cessation
-
2005
- 2005-07-06 NO NO20053312A patent/NO20053312L/no not_active Application Discontinuation
-
2006
- 2006-06-27 HK HK06107242A patent/HK1087105A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TWI281397B (en) | 2007-05-21 |
AU2004218161B9 (en) | 2009-11-26 |
RU2005131018A (ru) | 2006-02-10 |
KR20050105982A (ko) | 2005-11-08 |
MY137964A (en) | 2009-04-30 |
BRPI0407519A (pt) | 2006-02-14 |
CN1756753A (zh) | 2006-04-05 |
JPWO2004078751A1 (ja) | 2006-06-08 |
CN1326852C (zh) | 2007-07-18 |
EP1602655A1 (en) | 2005-12-07 |
AU2004218161B2 (en) | 2009-10-29 |
EP1602655A4 (en) | 2010-06-09 |
MXPA05009500A (es) | 2005-10-18 |
JP4528722B2 (ja) | 2010-08-18 |
NO20053312L (no) | 2005-10-04 |
TW200420292A (en) | 2004-10-16 |
US7314877B2 (en) | 2008-01-01 |
NZ541064A (en) | 2007-09-28 |
NO20053312D0 (no) | 2005-07-06 |
RU2328495C2 (ru) | 2008-07-10 |
CA2512280A1 (en) | 2004-09-16 |
WO2004078751A1 (ja) | 2004-09-16 |
US20060189621A1 (en) | 2006-08-24 |
AU2004218161A1 (en) | 2004-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1069396A1 (en) | Benzofuran derivative | |
HK1091204A1 (en) | Heteroarylcarbamoylbenzene derivative | |
HK1087105A1 (en) | Benzofuran derivative | |
IL169905A0 (en) | Novel 2-pyridinecarboxamide derivatives | |
IL176562A0 (en) | Amidopyrazole derivative | |
ZA200603879B (en) | Substituted indazole-O-glucosides | |
IL175490A0 (en) | Substituted indazole-o-glucosides | |
ZA200603880B (en) | Substituted indole-O-glucosides | |
HK1088326A1 (en) | Piperidine-benzenesulfonamide derivatives | |
EP1680131A4 (en) | SUBSTITUTED INDOLE-O-GLUCOSIDES | |
HK1089443A1 (en) | Imidazol-4-yl-ethynyl-pyridine derivatives | |
GB0317665D0 (en) | Qinazoline derivatives | |
PT1682493E (pt) | Derivados de aminoacetonitrilo | |
IL175189A0 (en) | N-thiazol-2-yl-benzamide derivatives | |
TWI368482B (en) | New 2-pyridinylethylbenzamide derivatives | |
ZA200600430B (en) | Substituted spirobenzazepines | |
IL174187A0 (en) | Carbamoyl-type benzofuran derivatives | |
SI1706373T1 (sl) | Amidoacetonitrilni derivati | |
GB0312368D0 (en) | Novel ureido- and amido-pyrazolone derivatives | |
GB0319793D0 (en) | Pyridinylmorpholine derivatives | |
GB0302330D0 (en) | Improved expression elements | |
AU2003280821A8 (en) | Beauveriolide derivative | |
GB0320548D0 (en) | Supports | |
TWI341309B (en) | Heteroarylcarbamoylbenzene derivatives | |
SI1654253T1 (sl) | Substituirani 3-pirolidin-indolni derivati |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110303 |